Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis.

Kovanda LL, Giamberardino C, McEntee L, Toffaletti DL, Franke KS, Bartuska A, Smilnak G, de Castro GC, Ripple K, Hope WW, Perfect JR.

Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00546-19. doi: 10.1128/AAC.00546-19. [Epub ahead of print]

2.

Population Pharmacokinetic Modeling of VL-2397, a Novel Systemic Antifungal Agent: Analysis of a Single- and Multiple-Ascending-Dose Study in Healthy Subjects.

Kovanda LL, Sullivan SM, Smith LR, Desai AV, Bonate PL, Hope WW.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00163-19. doi: 10.1128/AAC.00163-19. Print 2019 Jun.

PMID:
30988142
3.

Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans.

Bulitta JB, Hope WW, Eakin AE, Guina T, Tam VH, Louie A, Drusano GL, Hoover JL.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02307-18. doi: 10.1128/AAC.02307-18. Print 2019 May. Review.

4.

Hernia prevention: practice patterns and surgeons' attitudes about abdominal wall closure and the use of prophylactic mesh.

Fischer JP, Harris HW, López-Cano M, Hope WW.

Hernia. 2019 Apr;23(2):329-334. doi: 10.1007/s10029-019-01894-z. Epub 2019 Feb 8.

PMID:
30734888
5.

A Preliminary Assessment of Abdominal Wall Tension in Patients Undergoing Retromuscular Hernia Repair.

Tenzel PL, Johnson RG, Bilezikian JA, Powers WF, Hope WW.

Surg Technol Int. 2019 May 15;34:251-254.

PMID:
30716161
6.

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.

Andes DR, Ghannoum MA, Mukherjee PK, Kovanda LL, Lu Q, Jones ME, Santerre Henriksen A, Lademacher C, Hope WW.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01634-18. doi: 10.1128/AAC.01634-18. Print 2019 Jan.

7.

Rationale and Technique for Measuring Abdominal Wall Tension in Hernia Repair.

Hope WW, Williams ZF, Rawles JW 3rd, Hooks WB 3rd, Clancy TV, Eckhauser FE.

Am Surg. 2018 Sep 1;84(9):1446-1449.

PMID:
30268173
8.

Prophylactic Mesh for Hernia Prevention: Has the Time Arrived?

Fox SS, Johnson R, Fischer JP, Eckhauser F, Hope WW.

Plast Reconstr Surg. 2018 Sep;142(3 Suppl):180S-186S. doi: 10.1097/PRS.0000000000004876.

PMID:
30138288
9.

Measuring Success in Complex Abdominal Wall Reconstruction: The Role of Validated Outcome Scales.

Otero J, Arnold MR, Hope WW, Augenstein VA.

Plast Reconstr Surg. 2018 Sep;142(3 Suppl):163S-170S. doi: 10.1097/PRS.0000000000004873.

PMID:
30138285
10.

Abdominal Wall Reconstruction Risk Stratification Tools: A Systematic Review of the Literature.

Bernardi K, Adrales GL, Hope WW, Keith J, Kuhlens H, Martindale RG, Melin AA, Orenstein SB, Roth JS, Shah SK, Tsuda S, Liang MK; Ventral Hernia Outcomes Collaborative Writing Group.

Plast Reconstr Surg. 2018 Sep;142(3 Suppl):9S-20S. doi: 10.1097/PRS.0000000000004833.

PMID:
30138260
11.

Prophylactic mesh used in ileal conduit formation following radical cystectomy: a retrospective cohort.

Tenzel PL, Williams ZF, McCarthy RA, Hope WW.

Hernia. 2018 Oct;22(5):781-784. doi: 10.1007/s10029-018-1801-5. Epub 2018 Aug 10.

PMID:
30097796
12.

Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials.

Kovanda LL, Walsh TJ, Benjamin DK Jr, Arrieta A, Kaufman DA, Smith PB, Manzoni P, Desai AV, Kaibara A, Bonate PL, Hope WW.

Pediatr Infect Dis J. 2018 Jun;37(6):580-585. doi: 10.1097/INF.0000000000001957.

13.

Umbilical Hernia Repair: Overview of Approaches and Review of Literature.

Appleby PW, Martin TA, Hope WW.

Surg Clin North Am. 2018 Jun;98(3):561-576. doi: 10.1016/j.suc.2018.02.001. Epub 2018 Mar 12. Review.

PMID:
29754622
14.

Role of Prophylactic Mesh Placement for Laparotomy and Stoma Creation.

Rhemtulla IA, Messa CA 4th, Enriquez FA, Hope WW, Fischer JP.

Surg Clin North Am. 2018 Jun;98(3):471-481. doi: 10.1016/j.suc.2018.01.003. Review.

PMID:
29754617
15.

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.

Benjamin DK Jr, Kaufman DA, Hope WW, Smith PB, Arrieta A, Manzoni P, Kovanda LL, Lademacher C, Isaacson B, Jednachowski D, Wu C, Kaibara A, Walsh TJ.

Pediatr Infect Dis J. 2018 Oct;37(10):992-998. doi: 10.1097/INF.0000000000001996. Erratum in: Pediatr Infect Dis J. 2018 Nov;37(11):1198.

16.

Reducing Early Readmissions after Ventral Hernia Repair with the Americas Hernia Society Quality Collaborative.

Poulose BK, Harris DA, Phillips S, Janczyk RJ, Yunis J, Voeller GR, Carbonell A, Warren J, Stoikes N, Webb D, Hope WW, Rosen MJ; Americas Hernia Society Quality Collaborative.

J Am Coll Surg. 2018 May;226(5):814-824. doi: 10.1016/j.jamcollsurg.2018.01.048. Epub 2018 Feb 8.

PMID:
29428233
17.

Incisional Hernia in the United States: Trends in Hospital Encounters and Corresponding Healthcare Charges.

Shubinets V, Fox JP, Lanni MA, Tecce MG, Pauli EM, Hope WW, Kovach SJ, Fischer JP.

Am Surg. 2018 Jan 1;84(1):118-125.

PMID:
29428038
18.

Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers.

Felton TW, Ogungbenro K, Boselli E, Hope WW, Rodvold KA.

J Antimicrob Chemother. 2018 May 1;73(5):1340-1347. doi: 10.1093/jac/dkx541.

PMID:
29385448
19.

Clinical and Patient-Reported Outcomes after Absorbable Strap Fixation for Ventral Hernia Repair.

Bougard H, Bringman S, Hope WW, Redan JA, Doerhoff C, Chudy M, Romanowski C, Jones PC.

Surg Technol Int. 2017 Dec 22;31:83-92.

PMID:
29315451
20.

Invited comment to: European Hernia Society Guidelines on prevention and treatment of parastomal hernias.

Hope WW.

Hernia. 2018 Feb;22(1):201. doi: 10.1007/s10029-017-1694-8. No abstract available.

PMID:
29134452
21.

Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung.

Rodvold KA, Hope WW, Boyd SE.

Curr Opin Pharmacol. 2017 Oct;36:114-123. doi: 10.1016/j.coph.2017.09.019. Epub 2017 Oct 31. Review.

PMID:
29096171
22.

Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class I/high-risk ventral and incisional hernia repair: 18-month follow-up.

Roth JS, Anthone GJ, Selzer DJ, Poulose BK, Bittner JG, Hope WW, Dunn RM, Martindale RG, Goldblatt MI, Earle DB, Romanelli JR, Mancini GJ, Greenberg JA, Linn JG, Parra-Davila E, Sandler BJ, Deeken CR, Voeller GR.

Surg Endosc. 2018 Apr;32(4):1929-1936. doi: 10.1007/s00464-017-5886-1. Epub 2017 Oct 23.

PMID:
29063307
23.

An evaluation of abdominal wall closure in general surgical and gynecological residents.

Williams Z, Williams S, Easley HA, Seita HM, Hope WW.

Hernia. 2017 Dec;21(6):873-877. doi: 10.1007/s10029-017-1682-z. Epub 2017 Oct 22.

PMID:
29058132
24.

Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats.

Schmitt-Hoffmann AH, Kato K, Townsend R, Potchoiba MJ, Hope WW, Andes D, Spickermann J, Schneidkraut MJ.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01292-17. doi: 10.1128/AAC.01292-17. Print 2017 Dec.

25.

Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.

Negri CE, Johnson A, McEntee L, Box H, Whalley S, Schwartz JA, Ramos-Martín V, Livermore J, Kolamunnage-Dona R, Colombo AL, Hope WW.

J Infect Dis. 2018 Mar 13;217(7):1118-1127. doi: 10.1093/infdis/jix479. Erratum in: J Infect Dis. 2018 Apr 20;:.

26.

Pharmacodynamics of teicoplanin against MRSA.

Ramos-Martín V, Johnson A, McEntee L, Farrington N, Padmore K, Cojutti P, Pea F, Neely MN, Hope WW.

J Antimicrob Chemother. 2017 Dec 1;72(12):3382-3389. doi: 10.1093/jac/dkx289.

PMID:
28962026
27.

Suture to wound length ratio in abdominal wall closure: how well are we doing?

Williams ZF, Tenzel P, Hooks WB 3rd, Hope WW.

Hernia. 2017 Dec;21(6):869-872. doi: 10.1007/s10029-017-1667-y. Epub 2017 Sep 23.

PMID:
28942543
28.

Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.

Desai AV, Kovanda LL, Hope WW, Andes D, Mouton JW, Kowalski DL, Townsend RW, Mujais S, Bonate PL.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01034-17. doi: 10.1128/AAC.01034-17. Print 2017 Dec.

29.

Cracking Chests without a Scratch: A Review of Emergency Department Thoracotomy Outcomes and Injuries to Providers at a Level II Trauma Center.

Fox SS, Martin T, Williams ZF, Hope WW.

Am Surg. 2017 Sep 1;83(9):e384-e385. No abstract available.

PMID:
30454362
30.

Combination therapy for carbapenemase-producing Entero-bacteriaceae: INCREMENT-al effect on resistance remains unclear.

Boyd SE, Moore LSP, Rawson TM, Hope WW, Holmes AH.

Lancet Infect Dis. 2017 Sep;17(9):899-900. doi: 10.1016/S1473-3099(17)30450-4. No abstract available.

31.

Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease.

Hope WW, McEntee L, Livermore J, Whalley S, Johnson A, Farrington N, Kolamunnage-Dona R, Schwartz J, Kennedy A, Law D, Birch M, Rex JH.

MBio. 2017 Aug 22;8(4). pii: e01157-17. doi: 10.1128/mBio.01157-17.

32.

An Evaluation of Parastomal Hernia Repair Using the Americas Hernia Society Quality Collaborative.

Fox SS, Janczyk R, Warren JA, Carbonell AM 2nd, Poulose BK, Rosen MJ, Hope WW.

Am Surg. 2017 Aug 1;83(8):881-886.

PMID:
28822396
33.

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children.

Ramos-Martín V, Neely MN, Padmore K, Peak M, Beresford MW, Turner MA, Paulus S, López-Herce J, Hope WW.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00707-17. doi: 10.1128/AAC.00707-17. Print 2017 Oct.

34.

PHARMACOKINETICS OF ORALLY ADMINISTERED VORICONAZOLE IN AFRICAN PENGUINS (SPHENISCUS DEMERSUS) AFTER SINGLE AND MULTIPLE DOSES.

Hyatt MW, Wiederhold NP, Hope WW, Stott KE.

J Zoo Wildl Med. 2017 Jun;48(2):352-362. doi: 10.1638/2016-0160R2.1.

PMID:
28749255
35.

Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.

Petraitis V, Petraitiene R, McCarthy MW, Kovanda LL, Zaw MH, Hussain K, Shaikh N, Maung BBW, Sekhon NK, Hope WW, Walsh TJ.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00305-17. doi: 10.1128/AAC.00305-17. Print 2017 Sep.

36.

Incisional Hernia.

Hope WW, Waheed A, Tuma F.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 14.

37.

Abdominal Wall Reconstruction.

Hope WW, de la Torre JI.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 15.

38.

Laparoscopic Inguinal Hernia Repair.

Hope WW, Pfeifer C.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 15.

39.

Endpoint Assessment in Rabbit Models of Invasive Pulmonary Aspergillosis and Mucormycosis.

Petraitis V, Petraitiene R, Hope WW, Walsh TJ.

Methods Mol Biol. 2017;1625:259-277. doi: 10.1007/978-1-4939-7104-6_18.

PMID:
28584996
40.

Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response.

Kovanda LL, Kolamunnage-Dona R, Neely M, Maertens J, Lee M, Hope WW.

Clin Infect Dis. 2017 Jun 1;64(11):1557-1563. doi: 10.1093/cid/cix198. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

41.

SAGES clinical spotlight review: intraoperative cholangiography.

Hope WW, Fanelli R, Walsh DS, Narula VK, Price R, Stefanidis D, Richardson WS.

Surg Endosc. 2017 May;31(5):2007-2016. doi: 10.1007/s00464-016-5320-0. Epub 2017 Mar 31. No abstract available.

PMID:
28364147
42.

Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.

Stott KE, Hope WW.

J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i12-i18. doi: 10.1093/jac/dkx029. Review.

PMID:
28355463
43.

Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.

Kovanda LL, Marty FM, Maertens J, Desai AV, Lademacher C, Engelhardt M, Lu Q, Hope WW.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00101-17. doi: 10.1128/AAC.00101-17. Print 2017 Jun.

44.

Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis.

Kovanda LL, Desai AV, Hope WW.

J Pharmacokinet Pharmacodyn. 2017 Apr;44(2):143-151. doi: 10.1007/s10928-017-9509-1. Epub 2017 Feb 8. Review.

PMID:
28181136
45.

Does prophylactic mesh placement in elective, midline laparotomy reduce the incidence of incisional hernia? A systematic review and meta-analysis.

Borab ZM, Shakir S, Lanni MA, Tecce MG, MacDonald J, Hope WW, Fischer JP.

Surgery. 2017 Apr;161(4):1149-1163. doi: 10.1016/j.surg.2016.09.036. Epub 2016 Dec 28. Review.

46.

Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients.

Seibel NL, Shad AT, Bekersky I, Groll AH, Gonzalez C, Wood LV, Jarosinski P, Buell D, Hope WW, Walsh TJ.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01477-16. doi: 10.1128/AAC.01477-16. Print 2017 Feb.

47.

Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy.

Sime FB, Johnson A, Whalley S, Santoyo-Castelazo A, Montgomery AB, Walters KA, Lipman J, Hope WW, Roberts JA.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01763-16. doi: 10.1128/AAC.01763-16. Print 2017 Jan.

48.

F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase.

Oliver JD, Sibley GEM, Beckmann N, Dobb KS, Slater MJ, McEntee L, du Pré S, Livermore J, Bromley MJ, Wiederhold NP, Hope WW, Kennedy AJ, Law D, Birch M.

Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12809-12814. doi: 10.1073/pnas.1608304113. Epub 2016 Oct 25.

49.

Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children.

Lestner JM, Groll AH, Aljayyoussi G, Seibel NL, Shad A, Gonzalez C, Wood LV, Jarosinski PF, Walsh TJ, Hope WW.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7340-7346. doi: 10.1128/AAC.01427-16. Print 2016 Dec.

50.

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy.

Ramos-Martín V, Neely MN, McGowan P, Siner S, Padmore K, Peak M, Beresford MW, Turner MA, Paulus S, Hope WW.

J Antimicrob Chemother. 2016 Nov;71(11):3168-3178. Epub 2016 Aug 19.

Supplemental Content

Support Center